CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 3,521 enrolled
Drug / intervention
Hologic Selenia Dimensions Digital Breast Tomosynthesis Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00971087
NCT00971087N/ACompleted

A Multicenter, Controlled Clinical Trial to Evaluate the Hologic Tomosynthesis Mammography

Hologic, Inc.·interventional·Posted Sep 3, 2009·Updated Feb 26, 2025

In Brief

A clinical study evaluating Hologic Selenia Dimensions Digital Breast Tomosynthesis System for Breast Cancer. Completed, enrolled 3,521 participants across 22 sites.

Detailed Summary

The purpose of this image acquisition study is to compare, in a Reader Study, the performance of Tomosynthesis (3D) to (2D FFDM) conventional images in an enriched retrospective reader study. Synthetic 2D images, generated from the tomosynthesis image, will be available to the readers to provide an over view of the anatomy similar to a scout view in CT imaging and to determine whether the 3-D images with the synthesized 2D overview are non-inferior to the 2-D images alone as determined by receiver operating characteristic (ROC) area under the curve.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedSep 3, 2009
Enrollment StartSep 1, 2009
Primary CompletionSep 1, 2011
Study CompletionApr 1, 2012
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 16.8 years ago

Interventions

Hologic Selenia Dimensions Digital Breast Tomosynthesis Systemdevice

Subjects are exposed to the same number of investigational images collected on the investigational device (Selenia Dimensions Full Field Digital Mammography System). Subject enrollment occurs at the time subjects are being imaged for their standard of care mammographic work up (either screening mammogram or scheduled biopsy). All subjects undergoing a biopsy procedure will be imaged on the investigational device prior to their procedure.